Uterine Fibroid Clinical Trial
Official title:
Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)
SAGE is an observational post market registry with the objective of characterizing long term outcomes after treatment of uterine fibroids with the Sonata System in real world clinical practice settings.
Patients whom have selected the CE-marked Sonata system for treatment of fibroids will be approached for study participation. Participation in the trial will consist of data collection in the form of questionnaires prior to and after the treatment at the following intervals: pre-procedure, 4 weeks, 1, 2, 3, 4 and 5 years following treatment. The following data points will be collected: Length of stay, time to return to normal activities (Treatment Recovery Questionnaire), time to return to sexual activity (Treatment Recovery Questionnaire), change in fibroid symptom severity and quality of life (UFS-QOL), change in general health outcome (EQ-5D), work productivity and activity impairment (WPAI), subject satisfaction and overall treatment effect (Overall Treatment Effect and Satisfaction Questionnaire), pregnancy occurrence and outcome, non-medical re-intervention, adverse events related to the device/procedure. Validated questionnaires are used where appropriate (UFS-QOL, E1-5D and WPAI). Double data entry will occur to ensure accurate capture of subject reported data. Monitoring will occur throughout the course of the trial to ensure adherence to the protocol. As an observational trial, there are no pre-specified statistically powered endpoints. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04073485 -
Microwave Ablation for Uterine Fibroids
|
N/A | |
Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
Recruiting |
NCT01239641 -
High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids
|
Phase 4 | |
Recruiting |
NCT04748978 -
OPPIuM Technique and Myolysis With Diode Laser Dwls
|
N/A | |
Not yet recruiting |
NCT04191603 -
TWO DÄ°FFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY
|
N/A | |
Terminated |
NCT04132349 -
Ulipristal Acetate in Symptomatic Uterine Fibroid
|
Phase 4 | |
Completed |
NCT03412890 -
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
|
Phase 3 | |
Completed |
NCT03021720 -
Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial
|
N/A | |
Recruiting |
NCT04209036 -
Can 3D Laparoscopy Improve Surgical Performances in Surgeons in Training?
|
||
Completed |
NCT05086770 -
Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere
|
N/A | |
Recruiting |
NCT05416424 -
Life Study: Lifestyle Intervention in Fibroid Elimination
|
N/A | |
Not yet recruiting |
NCT05695690 -
Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification
|
||
Enrolling by invitation |
NCT06430320 -
Ascertaining Longterm Outcomes of Fibroid Treatments
|
||
Completed |
NCT04832906 -
UA Versus UAE in Treatment of Fibroids
|
Phase 4 | |
Completed |
NCT03444987 -
The Role of Fibroblast Activation in Uterine Fibroid
|
||
Active, not recruiting |
NCT06244251 -
Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
|
N/A | |
Not yet recruiting |
NCT06153667 -
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
|
||
Not yet recruiting |
NCT03450421 -
Safety and Efficacy of Actamaxâ„¢Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy
|
N/A | |
Not yet recruiting |
NCT05840042 -
Epidemiology and Risk Factors of Uterine Fibroids in China
|
||
Completed |
NCT04345003 -
MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids
|
N/A |